Arciniega J - Search Results

1

Validation of an anti-PA-ELISA for the potency testing of anthrax vaccine in mice.

Pombo M, Berthold I, Gingrich E, Jaramillo M, Leef M, Sirota L, Hsu H, Arciniega J. Pombo M, et al. Among authors: arciniega j. Biologicals. 2004 Sep;32(3):157-63. doi: 10.1016/j.biologicals.2004.03.002. Biologicals. 2004. PMID: 15536047

2

Potential application of the consistency approach for vaccine potency testing.

Arciniega J, Sirota LA. Arciniega J, et al. Dev Biol (Basel). 2012;134:135-9. Dev Biol (Basel). 2012. PMID: 22888606

3

Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.

Berthold I, Pombo ML, Wagner L, Arciniega JL. Berthold I, et al. Vaccine. 2005 Mar 14;23(16):1993-9. doi: 10.1016/j.vaccine.2004.10.014. Vaccine. 2005. PMID: 15734073

4

Ability of ELISA and a toxin neutralization assay to detect changes in immunogenicity of a recombinant Bacillus anthracis protective antigen vaccine upon storage.

Domínguez-Castillo RI, Verma A, Amador-Molina JC, Sirota L, Arciniega JL. Domínguez-Castillo RI, et al. Among authors: arciniega jl. Biologicals. 2013 Mar;41(2):111-4. doi: 10.1016/j.biologicals.2012.10.002. Epub 2012 Nov 6. Biologicals. 2013. PMID: 23137818

5

Feasibility of the use of ELISA in an immunogenicity-based potency test of anthrax vaccines.

Jiménez-Alberto A, Parreiras P, Castelán-Vega J, Sirota L, Arciniega J. Jiménez-Alberto A, et al. Among authors: arciniega j. Biologicals. 2011 Jul;39(4):236-41. doi: 10.1016/j.biologicals.2011.05.001. Epub 2011 Jun 12. Biologicals. 2011. PMID: 21664832

6

Temperature-mediated recombinant anthrax protective antigen aggregate development: Implications for toxin formation and immunogenicity.

Amador-Molina JC, Valerdi-Madrigal ED, Domínguez-Castillo RI, Sirota LA, Arciniega JL. Amador-Molina JC, et al. Among authors: arciniega jl. Vaccine. 2016 Jul 29;34(35):4188-4195. doi: 10.1016/j.vaccine.2016.06.057. Epub 2016 Jun 28. Vaccine. 2016. PMID: 27364097

7

Reduction of immunogenicity of anthrax vaccines subjected to thermal stress, as measured by a toxin neutralization assay.

Castelán-Vega J, Corvette L, Sirota L, Arciniega J. Castelán-Vega J, et al. Among authors: arciniega j. Clin Vaccine Immunol. 2011 Feb;18(2):349-51. doi: 10.1128/CVI.00267-10. Epub 2010 Dec 8. Clin Vaccine Immunol. 2011. PMID: 21147935 Free PMC article.

8

Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.

Parreiras PM, Sirota LA, Wagner LD, Menzies SL, Arciniega JL. Parreiras PM, et al. Among authors: arciniega jl. Vaccine. 2009 Jul 16;27(33):4537-42. doi: 10.1016/j.vaccine.2009.05.045. Epub 2009 Jun 6. Vaccine. 2009. PMID: 19501205

9

Adoption of three Rs alternatives for regulatory testing of vaccines in the developing world: possibilities and barriers.

Di Fabio JL, Jaramillo MT, Arciniega JL. Di Fabio JL, et al. Among authors: arciniega jl. Dev Biol (Basel). 2002;111:195-8. Dev Biol (Basel). 2002. PMID: 12678241

10

Report on the international workshop on alternatives to the murine histamine sensitization test (HIST) for acellular pertussis vaccines: state of the science and the path forward.

Isbrucker R, Arciniega J, McFarland R, Chapsal JM, Xing D, Bache C, Nelson S, Costanzo A, Hoonakker M, Castiaux A, Halder M, Casey W, Johnson N, Jones B, Doelling V, Sprankle C, Rinckel L, Stokes W. Isbrucker R, et al. Among authors: arciniega j. Biologicals. 2014 Mar;42(2):114-22. doi: 10.1016/j.biologicals.2013.11.011. Epub 2014 Jan 4. Biologicals. 2014. PMID: 24394373

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters